Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.
Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.
Recruiting · NCT06180382 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Phase 4 | 2026-05-05 | NCT06180382 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Hospitalier Universitaire de Saint Etienne | 129 |
| Takeda France | 1 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| APHM | Marseille | France | 5 |
| APHP - Hôpital Bicêtre | Le Kremlin-Bicêtre | France | 1 |
| Assistance Publique - Hôpitaux de Paris | Paris | France | 1 |
| Ch Lyon Sud | Pierre-Bénite | France | 1 |
| CHRU Lille | Lille | France | 17 |
| CHU Amiens | Amiens | France | 7 |
| CHU Bordeaux | Pessac | France | 12 |
| CHU de Saint-Etienne | Saint-Etienne | France | 37 |
| CHU Limoges | Limoges | France | 14 |
| CHU Montpellier | Montpellier | France | 23 |
| CHU Rennes | Rennes | France | 15 |
| Hôpital de l'Archet II | Nice | France | 1 |